Net Loss Per Share

6 Months Ended

Jun. 30, 2023

Basic net loss per share is computed by dividing net loss by the weighted average number of ordinary shares outstanding. Diluted net loss per share is computed by dividing net loss by the weighted-average number of ordinary shares outstanding, plus all additional ordinary shares that would have been outstanding, assuming dilutive potential ordinary shares had been issued for other dilutive securities. For the three and six months ended June 30, 2023 and 2022, diluted and basic net loss per ordinary share were identical since potential ordinary shares were excluded from the calculation, as their effect was anti-dilutive.


	Three Months Ended June 30, 2023		Three Months Ended June 30, 2022		Six Months Ended June 30, 2023		Six Months Ended June 30, 2022
Numerator
Net loss attributable to ordinary shareholders	$	(21,621)	$	(42,391)	$	(45,666)	$	(70,117)
Denominator
Weighted-average shares – basic and diluted	107,164,401		107,922,501		107,163,220		107,600,767
Net loss per ordinary share – basic and diluted	$	(0.20)	$	(0.39)	$	(0.43)	$	(0.65)

The following outstanding potentially dilutive securities were excluded from the calculation of diluted net loss per share, because including them would have been anti-dilutive during each period.


	As of
	June 30, 2023	June 30, 2022

Employee Share Options	16,503,634	13,183,057
Non-vested restricted share units	3,546,458	641,996

MyoKardia Warrant	170,000	170,000

Warrants in LianBio issued to QED and Tarsus	425,942	425,942